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Abstract 
 
Previous studies have reported that majority of antiretroviral (ARV) treatment-naïve patients use traditional 
medicine(TM). Given that TM use is ubiquitous in South Africa especially for chronic conditions, there is a potential for 
ARV non-adherence and serious drug interactions among patients with HIV/AIDs who use TM. The motivating factors 
for TM use in HIV/AIDS patients on ARV and prophylaxis treatment have not been well defined in South Africa. This 
study aimed to investigate the prevalence, facilitators, predictors, and types of TM used among persons living with 
HIV/AIDS on antiretroviral treatment. The study was a cross-sectional survey which involved 100 participants enrolled 
at ARV clinics in two South African provinces. Univariate and bivariate analyses were performed to assess the 
relationships between variables and potential predictors of TM. Sixteen percent of participants on ARV reported TM 
use. Seventy-nine percent used TM prior to a diagnosis of HIV. Participants were more likely to use TM if they were 
from a rural province, female, older, unmarried, employed, had limited education, or were HIV-positive for less than 
five years. TM users reported utilizing herbal or medicinal mixtures that were claimed to heal all conditions. This study 
provides insights into the treatment modalities selected by patients with HIV/AIDS in South Africa who are receiving 
ARV. This study revealed that less than 20% of participants co-used TM and ARV. However, close to 80% of 
participants utilize TM before contracting HIV, which is in keeping with approximate estimates by the WHO. 
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Introduction  
 
            Currently, there are approximately 20.8 million to 24.1 million individuals in sub-Saharan Africa living with the 
Human Immunodeficiency Virus and Acquired Immune Deficiency Syndrome (HIV/AIDS) (UNAIDS and WHO, 2009). 
Compared to other countries, South Africa is among the most severely affected by the HIV pandemic, with 
approximately 5.2 million people living with HIV and 1,000 AIDS-related deaths occurring every day (Statistics South 
Africa, 2009). The availability of antiretroviral (ARV) drug treatment for HIV-positive people enables them to maintain 
their health and lead relatively normal lives. Access to ARV therapy (ART) was initially limited to relatively few, due to 
the slow response of the South African Government to make ARV available to those who needed it. The Ministry of      
Health however, was actively promoting the use of traditional medicines (TM) (Mills et al., 2005). 
            According to the World Health Organisation, Traditional medicine is defined as the sum total of knowledge, 
skills and practices based on the theories, beliefs and experiences indigenous to different cultures that are used to 
maintain health, as well as to prevent, diagnose, improve or treat physical and mental illnesses (WHO, 2003). In 
developing countries, the use of traditional medicine has been based on availability, accessibility, cultural and social 
Hughes et al., Afr J Tradit Complement Altern Med. (2012) 9(4):470‐484 
Publisher: African Networks on Ethnomedicines 
Web page: /http://journals.sfu.ca/africanem/index.php/ajtcam/index 
  http://dx.doi.org/10.4314/ajtcam.v9i4.4 
471
acceptability and mind/body/spirit connection (Bodeker and Kroneberg, 2002; Elujoba et al., 2005; Homsy et al., 2004; 
Liverpool et al., 2004). The World Health Organisation estimates that up to 80% of people in Africa make use of 
traditional medicine for primary health care (WHO, 2003). Many South Africans weigh the benefits of using TM against 
benefits offered by conventional “western” medicine, especially when considering the treatment of chronic conditions.  
There is limited information about the use of TM among patients with HIV/AIDS receiving ART in South Africa, and if it 
is a common practice, little is known about how it is being used and how the use of TM may affect patient outcomes. 
A particular concern among healthcare practitioners is that the use of TM may promote non-adherence to life-
prolonging ART regimens. Also, the use of TM in combination with ARV may reduce the efficacy of ARV or produce 
adverse drug effects. Alternatively, TM may diminish side effects and toxicities of ARV and promote adherence. All of 
these are questions yet to be answered. There is a need for better understanding of the use of TM among patients 
already receiving treatment for HIV/AIDS, especially in South Africa. 
            This pilot study aimed to provide an assessment of the prevalence, facilitators, barriers and predictors of TM 
use with and without prophylaxis, and/or ARV among people living with AIDS (PLWA). The objectives were to identify 
how patients self-manage their symptoms of HIV/AIDS; to identify patients receiving prophylaxis and/or ARV who also 
use TM and/or other therapies; to identify the types of TM being used; to identify patients who discontinued ARV and 
utilize TM; and to explore reasons for use of TM among patients. 
 
 
Methodology 
Study setting  
 
This pilot study was conducted in two sites in South Africa: (1) Khayelitsha sub-district, an urban township in 
Cape Town with the highest antenatal HIV rate (32%) in the Western Cape Province; and (2) in the Sisonke Health 
District in rural KwaZulu-Natal (KZN) province with an estimated antenatal HIV rate of 28%.  
 
Study Design and Sample 
 
This study used a cross-sectional study design and was conducted from January through August 2009.  A 
non-random sampling procedure was used to select 50 patients per each facility surveyed. Using this sampling 
procedure, all patients meeting the inclusion criteria described below were recruited at the facility on the day of the 
interview until the required sample size was achieved. Patients were excluded if they did not wish to participate, or 
refused informed consent. 
 
Study participants 
 
Eligible participants were either men or women aged18 years and older. In addition, eligible participants were 
required to have a diagnosis of HIV/AIDS, had attended one of the clinic sites, and had received an ARV treatment 
regimen and/or prophylaxis as recommended by the South African National Guidelines for People Living with 
HIV/AIDS (National Department of Health, South Africa, 2004). 
 
Data Collection 
 
Data were collected utilizing a questionnaire administered by experienced interviewers. A structured 
questionnaire was developed based on the existing literature from studies of TM and ARV (Challand, 2005; Risa et 
al., 2002). The survey questionnaire which was administered to the patients included data on demographic 
information---gender, age, education, employment, income; health status and medical care; ARV treatment/regimen; 
traditional medicine knowledge and practice. The symptoms section of the questionnaire was derived from a 
standardized instrument (Banda et al., 2007; Peltzer and Phaswana-Mafuya, 2008). The following information was 
also collected from each participant: socio-demographic data; health status; knowledge and use of TM; perceptions of 
TM; symptoms; and symptom management. All interviewers had been trained for one week on the tools and operating 
procedures for data collection. Furthermore, prior to the start of data collection, each interviewer completed a 
refresher course on general research methodology. Informed consent was obtained from all participants. 
Questionnaires were administered in the local language for each region (i.e.: Zulu in KwaZuluNatal and isiXhosa in 
the Western Cape Province). 
 
Ethical Considerations 
 
The study protocol was approved by the Institutional Review Board and Ethics Committees at the 
Universities of KwaZulu Natal and Stellenbosch University in South Africa as well as the University of Missouri-
Columbia in the United States of America (USA). Permission to conduct the study at both ARV sites was granted by 
the Department of Health.  
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Statistical Methods 
 
Due to the small sample size used for this study, descriptive statistics were utilized predominantly. However, 
for exploratory purposes bivariate logistic regression analyses were implemented. The distribution of HIV/AIDS 
symptoms were ranked by the frequency in which they were reported in order to compare TM users to those who 
reported use of conventional medicines. The ranks were also evaluated to compare symptoms reported by patient’s 
gender. Additionally, symptoms of HIV/AIDS in the present study were compared to those described in Makoae et al 
(2005). All statistical analyses were performed using SAS 9.1.3. 
 
 
Results  
Demographic and Clinical Characteristics 
 
Of the 100 participants recruited in this study, 97 participants, including 50 (51.5%) from the urban, KZN 
region and 47 (48.5%) from the rural Khayelitsha completed the study questionnaire. There were 29 (29.9%) male 
participants and 68 (70.1%) females.  Three participants were excluded due to incomplete data. Demographic 
characteristics are described in Table (i) a & b. The median age for the sample was 37years (interquartile range 12.0).  
More than 79% of the respondents were classified as WHO HIV stage I or II. The majority of participants (73.2%) 
were never married; 16.5% were married or cohabiting, and 10.3% were either divorced or widowed. Most participants 
(83.5%) reported having children and majority were unemployed (79.4%). However, 39.2% reported that they had 
received funding from a government grant, whereas 38.1% reported not having any income at all. Nearly all 
respondents (92.8%) reported that they did not have health insurance. 
Most respondents (63%) reported living with HIV for a period of 1 to 5 years. All respondents stated that their 
CD4 count and viral load was being monitored regularly (this was also confirmed from the patient treatment card). 
Twenty-seven percent of the participants reported having other medical conditions besides HIV/AIDS.  
Respondents employed a variety of methods for self-managing their symptoms of HIV/AIDS. Most patients indicated 
that they had been managing their symptoms using conventional medicine (41%) or were being assisted by their 
family who provided them with spiritual care and prayers (34%). The remaining respondents indicated that they were 
using either a combination of therapies or “other” treatment type. Regardless of the treatment type reported, none of 
the respondents indicated that they had ever discontinued using ART for HIV/AIDS.  
 
Traditional Medicine 
 
Compared to conventional medicine, fewer patients reported that they had used any TM (84.5% versus 
15.5%, respectively). When TM was used it was generally self-administered (92.9%) and rarely administered by a 
traditional healer (7.1%). Most of the patients who responded to this question reported using TM prior to being 
diagnosed with HIV (78.6%).  An equal proportion of respondents also indicated that either they had decided to use 
TM on their own, or that their decision to use TM was influenced by family and friends (42.9%, respectively).  
The participants provided a variety of reasons for why they had chosen to use TM. A similar number of 
respondents indicated that they had used TM to gain strength, increase their appetite, and relieve symptoms of 
numbness, ulcers, and bad dreams (33%, respectively). Participants also indicated that they had used TM to stop the 
spread of shingles (8.3%) or for some other, unspecified reason (24.8%). The types of TM used also differed between 
patients. Approximately half of the patients indicated that they had taken a form of TM consisting of herbal mixtures 
and other medicinal mixtures. The most popular herbal mixture used was ubhejane which is believed to effectively 
treat all bodily conditions.   
Most patients (92.9%) who had used TM chose not to disclose their use to a healthcare professional. 
However, 42.9% of respondents indicated that they had shared information regarding their use of ARV with a TM 
practitioner/healer. An exploration of the reasons why most patients chose not to disclose their use of TM to a 
healthcare provider revealed that respondents believed that that disclosing this information would result in a lack of 
support and understanding, as well as the potential for punitive repercussions. 
 
Symptoms of HIV/AIDS 
 
Table (ii) presents the 25 most common symptoms of HIV/AIDS reported by study participants. The top 10 
reported symptoms were weakness (61.9%); headache (59.8%); fever (58.8%); muscle aches (55.7%); thirst (50.5%); 
numbness/tingling of feet or toes, painful joints, and fatigue (47.4%, respectively); depression and chills (46.4%, 
respectively). Most respondents reported experiencing more than one symptom, and 5 symptoms were experienced 
by at least 50% of the sample.  When all of the reported symptoms were evaluated, it was determined that 29 
symptoms were experienced by at least 33% of the sample.  
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Only two symptoms were experienced by at least 50% of the sample and 15 symptoms were experienced by 
at least 33%. The most prevalent symptoms were more likely to be experienced by a greater percentage of patients 
with HIV/AIDS in this South African study than in the study reported by Makoae et al. (2005). 
 
Descriptive Data for Personal Characteristics and Severity of Illness (N=97) 
Table 1 a: Distribution of Social and Demographic Characteristics for Total HIV/AIDS Sample by gender 
Personal Characteristics  
Female 
68(70.1%)  
Male 
29(29.9%) 
Total 
97(100%) 
Age (yr)    
    Median  35 43 37 
    IQR  11.5 12.5 12.0 
Education level    
    No schooling 7(10.3) 9(31.0) 16(16.5) 
    Less than high school 52(76.5) 19(65.5) 71(73.2) 
    Metric and higher education 9(13.2) 1(3.4) 10(10.3) 
Where do you live?    
    Urban (WC)  39(57.4) 11(37.9) 50(51.5) 
    Rural (KZN)  29(42.6) 18(62.1) 47(48.5) 
Marital status    
   Never married 57(83.8) 14(48.3) 71(73.2) 
   Married or cohabitating 7(10.3) 9(31.0) 16(16.5) 
   Divorced or widowed 4(5.9) 6(20.7) 10(10.3) 
Employment Status    
   Employed 15(22.1) 5(17.2) 20(20.6) 
   Unemployed 53(77.9) 24(82.8) 77(79.4) 
What is your source of income?    
   None 30(44.1) 7(24.1) 37(38.1) 
   Monthly salary (formal employment) 10(14.7) 2(6.9) 12(12.4) 
   Informal employment 8(11.8) 2(6.9) 10(10.3) 
   Grant 20(29.4) 18(62.1) 38(39.2) 
Do you have health insurance?    
   Yes 6(8.8) 1(3.4) 7(7.2) 
   No 62(91.2) 28(96.6) 90(92.8) 
Do you have children?    
   Yes 56(82.4) 25(86.2) 81(83.5) 
   No 12(17.6) 4(13.8) 16(16.5) 
When were you diagnosed HIV positive?    
   Less than a year 11(16.2) 9(31.0) 20(20.6) 
   1-5 years 45(66.2) 16(55.2) 61(62.9) 
   More than five years 12(17.6) 4(13.8) 16(16.5) 
Which WHO HIV stage have you been told you are in?    
   Stage I 34(50.0) 18(62.1) 52(53.6) 
   Stage II 21(30.9) 4(13.8) 25(25.8) 
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   Stage III 11(16.2) 4(13.8) 15(15.5) 
   Stage IV (AIDS stage) 1(1.5) 1(3.4) 2(2.1) 
   Not indicated/unknown 1(1.5) 2(6.9) 3(3.1) 
Which medication currently taking?    
   Only Prophylaxis 4(5.9) 4(13.8) 8(8.2) 
   Only ART 36(52.9) 8(27.6) 44(45.4) 
   Prophylaxis and ART 16(23.5) 6(20.7) 22(22.7) 
   Traditional Medicine and other 4(5.9) 3(10.3) 7(7.2) 
   Other 8(11.8) 8(27.6) 16(16.5) 
In general, how are you self-managing the symptoms?    
   Conventional medicine 24(35.8) 15(51.7) 39(40.6) 
   Conventional medicine and TM 3(4.5) 3(10.3) 6(6.3) 
   Conventional medicine and other 10(14.9) 2(6.9) 12(12.5) 
   Traditional medicine and other 3(4.5) 1(3.4) 4(4.2) 
   Assistance of family, Spiritual care & Prayers 26(38.8) 7(24.1) 33(34.4) 
   Other 1(1.5) 1(3.4) 2(2.1) 
Are you using any Traditional Medicine?    
   Yes 11(16.2) 4(13.8) 15(15.5) 
   No 57(83.8) 25(86.2) 82(84.5) 
Is anyone monitoring your CD4 count/ viral load?     
   Yes 68(100) 29(100) 97(100) 
In addition to HIV, do you have other medical conditions?  
   Yes 17(25.0) 9(31.0) 26(26.8) 
   No 51(75.0) 20(69.0) 71(73.2) 
 
Table 1b: Distribution of Select Characteristics for Traditional Medicine Users by gender (n=14 one missing from 15 
respondents) 
Characteristics 
Female 
n(%) 
Male 
 n(%) 
Total 
n(%) 
TM use prior to HIV diagnosis    
   Yes 7(70.0) 4(100.0) 11(78.6) 
   No 3(30.0) 0(0.0) 3(21.4) 
Who advised you to use TM?    
   Self 4(40.0) 2(50.0) 6(42.9) 
   Parents and Friends 4(40.0) 2(50.0) 6(42.9) 
   Other 2(20.0) 0(0.0) 2(14.3) 
Traditional Medicine is administered by    
   Self  9(90.0) 4(100.0) 13(92.9) 
   Traditional healer 1(10.0) 0(0.0) 1(7.1) 
Have you told your doctor/nurse that you are using TM? 
   Yes 0(0.0) 1(25.0) 1(7.1) 
   No 10(100.0) 3(75.0) 13(92.9) 
Have you told your traditional practitioner/healer that you 
are on ART? 
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   Yes 4(40.0) 2(50.0) 6(42.9) 
   No 6(60.0) 2(50.0) 8(57.1) 
 Have you ever discontinued ART? 
 
   
   No 10(100) 4(100) 14(100) 
 
 
Table 2: Top 25 Ranked HIV/AIDS Symptoms Reported 
Symptoms Rank Frequency Percentage 
Weakness 1 60 61.9 
Headache 2 58 59.8 
Fever 3 57 58.8 
Muscle Aches 4 54 55.7 
Thirst 5 49 50.5 
Numbness: Tingling of feet or toes 7 46 47.4 
Painful Joints 7 46 47.4 
Fatigue 7 46 47.4 
Depression 9.5 45 46.4 
Chills 9.5 45 46.4 
Memory Loss 11 44 45.4 
Headache & Dizziness 12 42 43.3 
Blurred vision 13 41 42.3 
Itchy Skin 15 40 41.2 
Coughing 15 40 41.2 
Shortness of Breath with Activity 15 40 41.2 
Night Sweats 17 38 39.2 
Difficulty Concentrating 18 37 38.1 
Fear & Worries 22 34 35.1 
Gastrointestinal: Gas or Bloating 22 34 35.1 
Gastrointestinal: Nausea 22 34 35.1 
 
Symptoms of HIV/AIDS in Conventional Medicine and TM Users 
 
Figures 1 and 2 present the distribution of the most prevalent HIV/AIDS symptoms among conventional 
medicine and TM users, respectively. The most prevalent symptoms reported by conventional medicine users were: 
weakness, headache, fever, muscle aches, thirst, painful joints, chills, depression, memory loss, and fatigue.  
The top ranked symptoms reported by patients who used TM are shown in Figure 2. Five of the top 10 symptoms 
from conventional medicine users (thirst, painful joints, chills, depression and memory loss) were not the top 
symptoms reported by the TM users.  
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Figure 1: Distribution of most prevalent symptoms for non-traditional medicine users* 
 
*Rank in parenthesis 
 
 
 
Figure 2: Distribution of most prevalent symptoms for traditional medicine users* 
 
*Rank in parenthesis 
 
 
The top ranked symptoms by gender are presented in Figures 3 and 4.  The prevalence and types of 
symptoms reported differed by the participant’s gender. Six of the 10 top ranked symptoms experienced by females 
(muscle aches, depression, painful joints, chills, memory loss and tingling of feet or toes) were not among the top 
ranked symptoms reported by males.  
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Figure 3: Distribution of most prevalent symptoms for females* 
 
*Rank in parenthesis 
Figure 4: Distribution of most prevalent symptoms for males* 
 
*Rank in parenthesis Predictors of TM Use 
 
Selected potential predictors of TM use are reported in Table (iii). Respondents were more likely to report 
using TM if they were from the rural setting in KZN province (21.3%, n=10) than from the urban setting in the Western 
Cape Province (10%; n=5). More females (16.2%; n=11) were likely to report using TM than males (13.8%; n=4). In 
addition, older respondents (ages 38 to 62) were more likely than younger respondents (ages 19 to 37) to use TM 
(17.4% vs. 13.7%, respectively). Those with no formal education were more likely than those with at least some 
formal education (31.3% vs. 12.4%) to report usage of TM. Furthermore, patients who were not married were more 
likely to report using TM than patients who were (25% vs. 13.6%, respectively), the employed were more likely than 
the unemployed (20% vs. 14.3%, respectively), and those who had been HIV-positive for less than five years were 
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more likely to report using TM than those who had been HIV-positive for five years or more (16.1% vs. 12.5, 
respectively). 
 
 
Table 3: Traditional Medicine by Select Potential Predictors 
PREDICTOR Traditional Medicine, % (N) 
Gender Male 13.8 (4) 
 Female 16.2 (11) 
Age Young (ages 19-37) 13.7 (7) 
 Older (ages 38-62) 17.4 (8) 
Residence  Urban 10.0 (5) 
 Rural 21.3 (10) 
Education No Schooling 31.3 (5) 
 Some Education 12.4 (10) 
Province WC 10.0 (5) 
 KZN 21.3 (10) 
Marital Status Married 13.6 (11) 
 Not Married 25.0 (4) 
Household Type Spouse and/or Kids 14.8 (12) 
 Other 20.0 (3) 
Employment Status Employed 20.0 (4) 
 Not Employed 14.29 (11) 
Income Source No Income Source 6.5 (2) 
 Source of Income 21.7 (13) 
Health Insurance Insurance 14.3 (1) 
 No Insurance 15.6 (14) 
Children Yes 17.8 (14) 
 No 6.3 (1) 
HIV positive 5+ yrs Yes 12.5 (2) 
 No 16.1 (13) 
 
Bivariate logistic regression results from selected potential predictors of TM usage are shown in Figure 5.  
 
Figure 5: Bivariate Logistic Regression of Traditional Medicine by Select Potential Predictors 
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None of the relationships between patient characteristics and TM use were statistically significant. This is 
most likely due to the small sample size analyzed in this pilot study. However, some of the findings are worth noting. 
Those in the rural setting in KZN province who were married and those with children were more than twice as likely to 
use TM. In the urban setting in the Western Cape Province, those with some formal education, no income sources, 
and those reporting using ART, were all twice as unlikely to use TM. 
Figures 6 to 8 display TM usage by monthly household income; monthly food expenses; and by monthly 
healthcare–facility-related medical expenses, respectively. In this study, TM users had higher median household 
incomes (displayed in the local currency of South African Rands [R]) than conventional medicine users (R1500 vs 
R1200, respectively). Users of TM also had lower monthly food expenses (R500 vs R700, respectively) and higher 
healthcare–facility-related medical expenses than non-users (R240 vs. R200, respectively). 
 
Figure 6:  Box plots of Traditional Medicine Usage by Monthly Household Income* 
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Figure 7:  Box plots of Traditional Medicine Usage by Monthly Food Expenses† 
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Figure 8: Box plots of Traditional Medicine Usage by Monthly Healthcare Facility Medicine Expenses‡ 
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Discussion 
 
This pilot study provides a foundation for future research by determining the prevalence of and predictors for 
TM use among PLWA on prophylaxis treatment and ARV in both rural and urban settings. Approximately 15% of 
participants reported using TM; however, this percentage is lower than the estimates reported in other surveys 
(Challand, 2005; Dhalla et al., 2006; Kasilo, 2000; Peltzer et al., 2008; Risa et al., 2002; Wiwanitikit, 2003). Most 
participants in this pilot study admitted that they did not disclose their use of TM to healthcare workers out of fear of 
repercussions (because they were combining prescribed treatments with TM against the advice of healthcare 
workers).  The participants also stated that admitting to use of TM may negatively impact the healthcare they received 
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(Banda et al., 2007).It is believed that the true prevalence of TM use exceeds the prevalence observed during this 
study. 
Respondents in rural areas were more likely to use TM in combination with ART or prophylaxis, while the respondents 
from the urban site tended to rely on family support, spiritual care and prayer. Participants who reported using TM 
indicated that they started using it before they were diagnosed with HIV/AIDS. Once ART were prescribed, 
respondents continued to use TM, but did not disclose their use to a healthcare provider due to the reasons previously 
described. However, the respondents did disclose their use of TM to their traditional healer. Patients who disclosed 
their use of TM to a traditional healer did so because they had spent time with the traditional healer and had 
established a relationship of trust and a cultural connection. Traditional healers have been known to provide client-
centered, personalized care that is tailored to meet the needs and expectations of their patients. This establishes 
traditional healers as strong agents for communicating health and social issues. In South Africa, traditional healers 
enjoy greater credibility than do health workers, especially with respect to social and spiritual matters (Dambisya and 
Tindimwebwa, 2003; UNAIDS, 2002).Most participants who had used TM were in the early stages of HIV. These 
respondents reported that they had been using TM for reasons other than HIV and continued with TM after they had 
been diagnosed with HIV. Once the HIV had progressed, these participants tended to rely primarily on family support, 
prayer, spiritual healing, and other forms of treatment. However, additional studies may be useful for exploring the 
reasons why patients in a higher disease stage choose to use treatments other than TM or conventional medicine.  
There was a difference in the ARV regimens prescribed at the two study sites, with most participants in the KZN 
province (85.1%) receiving regimen 1A (DAT, 3TC, EFV), while participants in the Western Cape Province, received a 
variety of regimens. However, all of the prescribed regimens were in alignment with the South African Antiviral 
Treatment Guidelines for ART (National Department of Health South Africa, 2004). It is therefore not surprising that 
45% of all patients were on regimen 1A (D4T, 3TC, EFV) and 1B; and 2.7% were on regimen 1A, 1B and 2. 
The South African National Guidelines states that cotrimoxazole prophylaxis must be continued in all patients on ART 
until the CD4 count is >200 cells/mm3 (National Department of Health South Africa, 2004). In this study, 22 (22.7%) 
respondents were on both prophylaxis and ARV, which adheres to the guidelines. 
There was some uncertainty with regards to the patient’s knowledge of their disease stage. Only 2 (2.06%) 
patients reported being in stage IV, while 95% reported that they were in stages I-III. However, these data contradict 
the number of years each patient reported that they had been living with HIV. Twenty-one percent of participants 
reported living with HIV for less than one year, 63%reported that they had been living with HIV for one to five years, 
and 17% for more than five years. In addition, according to South African guidelines, the criteria for ARV treatment 
includes a CD4 count of <200 cells/mm3 irrespective of WHO stage, or WHO Stage IV disease irrespective of CD4 
count; the patient must also express a willingness and readiness to adhere to their ARV regimen. These criteria 
confirm that more than the reported 2% of patients were actually in WHO stage IV.   
As reported, the top 10 symptoms of HIV/AIDS included: weakness, headaches, fever, muscle aches, thirst, 
painful joints, fatigue, tingling of feet/toes, depression and chills. Most of the symptoms were similar to those 
previously reported in the literature (Banda et al., 2007; Peltzer and Phaswana-Mafuya, 2008; Voss et al., 2007). 
Makoae et al. (2005) also ranked symptoms of HIV/AIDS. In their report of participants in Botswana, Lesotho, South 
Africa, and Swaziland, the top 10 reported symptoms were similar to those reported by our South African study 
population. However, instead of thirst, numbness/tingling of feet and toes, and fever reported by participants in the 
current study, respondents in the Makoae et al. (2005) study reported concerns over weight loss (47.9%), various 
fears or worries (45.4%), coughing (45.2%), lack of appetite (44.4%) and night sweats (40.6%). 
The majority of participants using TM reported doing so in order to increase their level of energy and to 
improve their strength. These results correlate with reported symptoms of muscle weakness and fatigue. There were 
many other reasons why some participants chose to use TM including a belief that TM could counteract the effects of 
witchcraft. Most respondents who reported using TM indicated that they had taken a medicinal mixture that was 
believed to heal all conditions (zifozonke). The most popular medicinal mixture was ubhejane. This was most likely 
because using the mass media to disseminate this message, the former Minister of Health recommended the use of 
this mixture (Bateman, 2006). In addition, some participants reported taking vitamins. Similar findings of participants 
using a variety of remedies including vitamins and herbs have been reported (Kroesena et al., 2002). 
There were several limitations to this pilot study including the small sample size; the small number of male 
participants; an inability to verify each participant’s response to questions regarding their disease stage; and possible 
selection bias due to recruitment occurring at the two ARV clinics. Due to the small sample size, the results are not 
generalizeable and are limited to similar populations with HIV/AIDS who attend ARV/ART clinics. 
There were numerous challenges experienced during the execution of this study.  According to the field 
workers, there was an inability for most participants to understand the differences between HIV and AIDS; to most 
participants, they were one and the same. In addition, only one participant was able to differentiate between 
prophylaxis and ARV. None of the participants knew what treatment regimen they were receiving, instead, field 
workers had to obtain this information from medical cards and/or medical records; and only one participant was able 
to recall their prescribed tablets and pills by name. TM is used as a complement to ART regimens and less often as a 
replacement. Therefore healthcare providers should openly and non-judgmental ask patients about their TM use for 
better understanding and appropriate treatment. 
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Conclusion 
 
This pilot study provides insight into the treatment modalities selected by patients with HIV/AIDS in South  
Africa who are receiving ARV. However, attempts at estimating the prevalence of TM use in the current study 
revealed TM usage at a lower rate than reported in other surveys. There is a need to better understand the use of 
traditional medicine with conventional medicine for HIV/AIDS prophylaxis and/or treatment. Understanding that 
patient’s may use both of these treatment types and others, is especially important in rural areas where traditional 
medicine is also utilized for the treatment of chronic conditions including those related and unrelated to HIV/AIDS. As 
patients advance in their HIV/AIDS disease, they are more likely to use alternative therapies such as prayer, 
spirituality, and family support to treat their condition. These alternative therapies need to be better understood and 
assessed as viable forms of healing. In the current study, respondents with fewer years of education were unable to 
differentiate between HIV and AIDS. In general, patients had limited knowledge about their disease stage and only a 
small proportion of participants were aware of their prescribed treatment regimen. Therefore, it is important that the 
healthcare workers remain vigilant in their efforts to educate patients with HIV/AIDS. The failure of governments to 
appropriately and quickly respond to the AIDS pandemic is especially disconcerting and ethically challenging.  
Currently, many individuals with CD4 counts below 350 are not able to access treatment.  The high-cost of treatment, 
governments incapable of or unwilling to provide ART, and the available selection of treatments may limit access to 
life-prolonging therapies.  Many believe that the peak response of ART has been reached and the future looks very 
grim. The need to find low-cost, local alternatives that can help individuals manage their disease as best as possible 
is both ethical and imperative. There is also a need to better understand the role of traditional healers in the treatment 
of HIV/AIDS and to explore whether collaboration or cooperation with traditional healers will ultimately improve patient 
outcomes and provide healthcare professionals with more reliable estimates of the prevalence, frequency, and the 
duration of TM use. Subsequent studies utilizing larger and more diverse samples are needed to provide a more 
accurate estimate of the true prevalence of TM among patients already on ARV, as they will be better powered to 
detect significant differences in potential clinical and demographic predictors of use.  Additional goals of any future 
research endeavour include an assessment of the benefits and/or risks associated with TM use, an exploration of the 
impact of HIV/AIDS treatment availability and cost on health outcomes in South Africa; and an evaluation of the role of 
TM in ameliorating access to inexpensive treatment options.  
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